WALTHAM, Mass., July 12, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ:NURO) announced today that it
plans to issue its 2018 second quarter financial results before the opening of the market on Thursday, July 19, 2018. The
Company will host a conference call at 8:00 a.m., Eastern Time on July 19, 2018 to discuss its financial
results as well as business developments affecting the Company.
The conference call may be accessed in the United States by dialing 844-787-0799 and using the confirmation code
7894528. Internationally, the conference call may be accessed by dialing 661-378-9630 and using the same confirmation code. The
earnings press release and accompanying condensed financial statements will be accessible from the Company's website
at www.NeuroMetrix.com under the "Investor Relations" tab.
A replay of the conference call will be available starting two hours after the call by dialing 855-859-2056, domestically and
404-537-3406, internationally. The confirmation code to access the replay is 7894528. The replay will be available for one week
after the conference call.
About NeuroMetrix
NeuroMetrix is an innovation driven healthcare company combining neurostimulation and digital medicine to address chronic
health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell®, an
over-the-counter wearable therapeutic device for chronic pain. The company also markets DPNCheck®, a rapid point-of-care
test for diabetic neuropathy, which is the most common long-term complication of Type 2 diabetes. For more information, please
visit NeuroMetrix.com.
NeuroMetrix, Inc.
Thomas T. Higgins, 781-314-2761
SVP and Chief Financial Officer
neurometrix.ir@neurometrix.com
Source: NeuroMetrix, Inc.
